Complement-Fixing Antiperipheral Myelin Antibodies and C9 Neoantigen in Serum of Patients with Guillain-Barré Syndrome: Quantitation, Kinetics, and Clinical Correlation
- 1 August 1987
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 505 (1) , 319-325
- https://doi.org/10.1111/j.1749-6632.1987.tb51300.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Clinical correlation with anti‐peripheral‐nerve myelin antibodies in Guillain‐Barré syndromeAnnals of Neurology, 1986
- BENEFICIAL EFFECTS OF PLASMA EXCHANGE IN ACUTE INFLAMMATORY POLYRADICULONEUROPATHYThe Lancet, 1984
- In vivo demyelinating activity of sera from patients with Guillain‐Barré syndromeAnnals of Neurology, 1982
- Degradation of the P0, P1, and Pr, Proteins in Peripheral Nervous System Myelin by Plasmin: Implications Regarding the Role of Macrophages in Demyelinating DiseasesJournal of Neurochemistry, 1981
- Immunological characterization of surd nerve biopsies from patients with Guillain-Barr syndromeAnnals of Neurology, 1981
- Cell-mediated immunity in idiopathic polyneuritisAnnals of Neurology, 1981
- Guillain-Barré syndrome: Demonstration of antibodies to peripheral nerve tissueActa Neurologica Scandinavica, 1978
- Production of the second component of complement by human monocytes: stimulation by antigen-activated lymphocytes or lymphokines.The Journal of Experimental Medicine, 1977
- IN VITRO DEMYELINATION OF PERIPHERAL NERVE INDUCED WITH SENSITIZED CELLS*Annals of the New York Academy of Sciences, 1965
- Thirty-eight Cases of the Guillain-Barre Syndrome: An Immunological StudyBMJ, 1963